Chinese Biotech Firm Biotheus Raises $26M In A New Round

Biotheus, a Chinese biotech firm, has raised RMB180 million (US$25.83 million) in a new funding round from a Zhuhai government-owned investment firm, Highlight Capital, a venture capital firm, and Zhuhai Huajin Asset Co. Ltd.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

1 COMMENT

  1. This is journalist, author and global cancer patient advocate Jamie Reno. I would like to contact Biothus, there is very little information online about the company. Is there a website? A contact email? Many thanks. Jamie

LEAVE A REPLY